Origin Stock

originww.comHealthcareFounded: 2010

Origin allows for the targeted delivery of nitric oxide, produced at the point of therapy from room air, in a vehicle, thermal plasma, which facilitates delivery of the nitric oxide to the specific tissues requiring treatment.

Register for Details

For more details on financing and valuation for Origin, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Origin in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$453MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$263MM